Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-007844
Filing Date
2020-08-21
Accepted
2020-08-21 16:05:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27677
2 filename2.txt TEXT-EXTRACT 1526
  Complete submission text file 0000000000-20-007844.txt   40614
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filed for) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations